Page last updated: 2024-12-05

naphthacene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Naphthacene is a polycyclic aromatic hydrocarbon (PAH) with the formula C18H12. It is a yellow solid that is poorly soluble in most solvents. Naphthacene is a planar molecule consisting of four fused benzene rings. It has a linear structure and has been studied extensively for its potential applications in organic electronics, organic light-emitting diodes (OLEDs), and solar cells. Naphthacene has also been investigated for its photophysical properties, which have potential uses in sensors and optical materials. The compound is a valuable building block in the synthesis of other molecules with interesting properties, such as the production of acenes, which are known for their potential use in organic electronics. Naphthacene has also been studied for its biological activity, including its potential as an antibacterial agent. It exhibits fluorescence upon UV irradiation.'

tetracene : An acene that consists of four ortho-fused benzene rings in a rectilinear arrangement. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7080
CHEMBL ID1797272
CHEBI ID32600
MeSH IDM0469047

Synonyms (39)

Synonym
naphthacene
smr000059178
MLS000028646
ccris 1183
benz(b)anthracene
einecs 202-138-9
2,3-benzanthrene
rubene
chrysogen
CHEBI:32600 ,
tetracene
92-24-0
2,3-benzanthracene
benz[b]anthracene
benz[b]anthracene, 98%
FT-0695324
N0001
CHEMBL1797272
qyj5z6712r ,
unii-qyj5z6712r
naphthacene [mi]
DTXSID4059045
AKOS024290196
tetracen
methacene
benzo[b]anthracene
N0951
benz[b]anthracene, sublimed grade, 99.99% trace metals basis
mfcd00003702
benz[b]anthracene, analytical standard
NS-00087
FT-0733642
Q379089
naphthacene (purified by sublimation)
naphthacene, benz[b]anthracene;tetracene, naphthacene, benz[b]anthracene
A854684
YSWG767
SB66520
2,3-benzanthracene, naphthacene, tetracene
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
aceneA polycyclic aromatic hydrocarbon consisting of fused benzene rings in a rectilinear arrangement.
tetracenesCompounds containing a tetracene skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (5.88)18.7374
1990's0 (0.00)18.2507
2000's14 (41.18)29.6817
2010's18 (52.94)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.36 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index69.20 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (45.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]